Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss inDe NovoKidney Transplant Recipients: A Randomized Controlled Trial

A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism

(2014) P. Evenepoel et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Temporal Trends in the Incidence, Treatment and Outcomes of Hip Fracture After First Kidney Transplantation in the United States

(2014) S. Sukumaran Nair et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Paricalcitol for Secondary Hyperparathyroidism in Renal Transplantation

(2014) M. Trillini et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial

(2013) H. Amer et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Osteoimmunology and Its Implications for Transplantation

(2013) R. Pacifici   AMERICAN JOURNAL OF TRANSPLANTATION

Bone and mineral disorders after kidney transplantation: Therapeutic strategies

(2013) Miklos Z. Molnar et al.   Transplantation Reviews

A 1-Year Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation

(2012) K. T. Smerud et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Common Infections in Kidney Transplant Recipients

(2012) S. Karuthu et al.   Clinical Journal of the American Society of Nephrology

Bone disease in CKD

(2012) Susan M. Ott   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Characteristics of Bisphosphonate-Related Osteonecrosis of the Jaw After Kidney Transplantation

(2012) Wonse Park et al.   JOURNAL OF CRANIOFACIAL SURGERY

Reduced Fracture Risk With Early Corticosteroid Withdrawal After Kidney Transplant

(2011) L. E. Nikkel et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Effects of denosumab on fracture and bone mineral density by level of kidney function

(2011) Sophie A Jamal et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prevention of Fractures after Solid Organ Transplantation: A Meta-Analysis

(2011) Emily M. Stein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?

(2011) N. B. Watts et al.   OSTEOPOROSIS INTERNATIONAL

The RANKL Pathway and Denosumab

(2011) Robin K. Dore   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Bisphosphonate Use in Chronic Kidney Disease: Association with Adynamic Bone Disease in a Bone Histology Series

(2010) Richard Amerling et al.   BLOOD PURIFICATION

Do RANKL inhibitors (denosumab) affect inflammation and immunity?

(2010) S. Ferrari-Lacraz et al.   OSTEOPOROSIS INTERNATIONAL

Open-Label Trial: Effect of Weekly Risedronate Immediately After Transplantation in Kidney Recipients

(2010) José-Vicente Torregrosa et al.   TRANSPLANTATION

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

(2009) David L Kendler et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Approach to the Patient with Transplantation-Related Bone Loss

(2009) Peter R. Ebeling   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone disease after renal transplantation

(2009) Hartmut H. Malluche et al.   Nature Reviews Nephrology

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bisphosphonates and Bone Fractures in Long-term Kidney Transplant Recipients

(2009) Emily Conley et al.   TRANSPLANTATION

Risk of Fractures After Renal Transplantation in the United States

(2009) Lucas E. Nikkel et al.   TRANSPLANTATION